Juan Carlos
Vallejo Llamas
Hospital Universitario Reina Sofia
Córdoba, EspañaPublications in collaboration with researchers from Hospital Universitario Reina Sofia (9)
2021
-
Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group
Transplant Infectious Disease, Vol. 23, Núm. 4
-
Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment
Bone Marrow Transplantation, Vol. 56, Núm. 6, pp. 1281-1290
-
Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group
American Journal of Transplantation, Vol. 21, Núm. 1, pp. 258-271
-
Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)
European Journal of Haematology, Vol. 106, Núm. 6, pp. 842-850
2013
-
Tratamiento de infecciones fúngicas en pacientes hematológicos de alto riesgo. La respuesta de AmBisome no se modifica con el uso previo de azoles de amplio espectro
Revista Espanola de Quimioterapia, Vol. 26, Núm. 1, pp. 64-69
2011
-
Update on bacteraemia in oncology and hematology
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL. 4, pp. 48-53
2006
-
Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: Influence of stem cell source [13]
Leukemia
-
Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia
Bone Marrow Transplantation, Vol. 37, Núm. 1, pp. 33-40
2001
-
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation
British Journal of Haematology, Vol. 114, Núm. 4, pp. 931-936